P-103: Real World Data on Efficacy and Safety of Low-Dose Direct Oral Anticoagulants (DOACs) for Venous Thromboembolism (VTE) Prophylaxis in Newly Diagnosed Multiple Myeloma

Discussant(s)

• 

  Andrew J. Yee, MD

  Clinical Director, Center for Multiple Myeloma
  Massachusetts General Hospital Cancer Center
  Boston, Massachusetts, United States

Poster Presenter(s)

• 

  Diana Basali, MD

  Hematology/Oncology Fellow
  Cleveland Clinic
  Pepper Pike, Ohio, United States